159 related articles for article (PubMed ID: 16454739)
21. CB(1) and CB(2) receptor-mediated signalling: a focus on endocannabinoids.
McAllister SD; Glass M
Prostaglandins Leukot Essent Fatty Acids; 2002; 66(2-3):161-71. PubMed ID: 12052033
[TBL] [Abstract][Full Text] [Related]
22. Are anandamide and cannabinoid receptors involved in ethanol tolerance? A review of the evidence.
Hungund BL; Basavarajappa BS
Alcohol Alcohol; 2000; 35(2):126-33. PubMed ID: 10787386
[TBL] [Abstract][Full Text] [Related]
23. In vivo pharmacology of endocannabinoids and their metabolic inhibitors: therapeutic implications in Parkinson's disease and abuse liability.
Giuffrida A; McMahon LR
Prostaglandins Other Lipid Mediat; 2010 Apr; 91(3-4):90-103. PubMed ID: 19523530
[TBL] [Abstract][Full Text] [Related]
24. Effects of cannabinoids on ligand-gated ion channels.
Oz M; Yang KS; Mahgoub MO
Front Physiol; 2022; 13():1041833. PubMed ID: 36338493
[TBL] [Abstract][Full Text] [Related]
25. A synthetic cannabinoid, CP55940, inhibits lipopolysaccharide-induced cytokine mRNA expression in a cannabinoid receptor-independent mechanism in rat cerebellar granule cells.
Chiba T; Ueno S; Obara Y; Nakahata N
J Pharm Pharmacol; 2011 May; 63(5):636-47. PubMed ID: 21492165
[TBL] [Abstract][Full Text] [Related]
26. Cannabinoid signalling in the enteric nervous system.
Galligan JJ
Neurogastroenterol Motil; 2009 Sep; 21(9):899-902. PubMed ID: 19689654
[TBL] [Abstract][Full Text] [Related]
27. The endocannabinoid system: physiology and pharmacology.
Rodríguez de Fonseca F; Del Arco I; Bermudez-Silva FJ; Bilbao A; Cippitelli A; Navarro M
Alcohol Alcohol; 2005; 40(1):2-14. PubMed ID: 15550444
[TBL] [Abstract][Full Text] [Related]
28. Cannabinoid receptors and endocannabinoids: evidence for new players.
Mackie K; Stella N
AAPS J; 2006 Apr; 8(2):E298-306. PubMed ID: 16796380
[TBL] [Abstract][Full Text] [Related]
29. Inhibition of [3H]batrachotoxinin A-20alpha-benzoate binding to sodium channels and sodium channel function by endocannabinoids.
Duan Y; Zheng J; Nicholson RA
Neurochem Int; 2008 Feb; 52(3):438-46. PubMed ID: 17888543
[TBL] [Abstract][Full Text] [Related]
30. Cannabinoid receptor ligands as potential anticancer agents--high hopes for new therapies?
Oesch S; Gertsch J
J Pharm Pharmacol; 2009 Jul; 61(7):839-53. PubMed ID: 19589225
[TBL] [Abstract][Full Text] [Related]
31. Endocannabinoids and Their Pharmacological Actions.
Pertwee RG
Handb Exp Pharmacol; 2015; 231():1-37. PubMed ID: 26408156
[TBL] [Abstract][Full Text] [Related]
32. Role of endocannabinoids and endovanilloids in Ca2+ signalling.
De Petrocellis L; Di Marzo V
Cell Calcium; 2009 Jun; 45(6):611-24. PubMed ID: 19356798
[TBL] [Abstract][Full Text] [Related]
33. Cannabinoids and haemostasis.
Zakrzeska A; Grędziński T; Kisiel W; Chabielska E
Postepy Hig Med Dosw (Online); 2016 Jul; 70(0):760-74. PubMed ID: 27383573
[TBL] [Abstract][Full Text] [Related]
34. Differential effects of endogenous and synthetic cannabinoids on alpha7-nicotinic acetylcholine receptor-mediated responses in Xenopus Oocytes.
Oz M; Zhang L; Ravindran A; Morales M; Lupica CR
J Pharmacol Exp Ther; 2004 Sep; 310(3):1152-60. PubMed ID: 15102930
[TBL] [Abstract][Full Text] [Related]
35. Endocannabinoid structure-activity relationships for interaction at the cannabinoid receptors.
Reggio PH
Prostaglandins Leukot Essent Fatty Acids; 2002; 66(2-3):143-60. PubMed ID: 12052032
[TBL] [Abstract][Full Text] [Related]
36. Anandamide suppression of Na+ currents in rat dorsal root ganglion neurons.
Kim HI; Kim TH; Shin YK; Lee CS; Park M; Song JH
Brain Res; 2005 Nov; 1062(1-2):39-47. PubMed ID: 16256960
[TBL] [Abstract][Full Text] [Related]
37. Endocannabinoid signalling triggered by NMDA receptor-mediated calcium entry into rat hippocampal neurons.
Ohno-Shosaku T; Hashimotodani Y; Ano M; Takeda S; Tsubokawa H; Kano M
J Physiol; 2007 Oct; 584(Pt 2):407-18. PubMed ID: 17615096
[TBL] [Abstract][Full Text] [Related]
38. Identification of endocannabinoids and cannabinoid CB(1) receptor mRNA in the pituitary gland.
González S; Manzanares J; Berrendero F; Wenger T; Corchero J; Bisogno T; Romero J; Fuentes JA; Di Marzo V; Ramos JA; Fernández-Ruiz J
Neuroendocrinology; 1999 Aug; 70(2):137-45. PubMed ID: 10461028
[TBL] [Abstract][Full Text] [Related]
39. The complications of promiscuity: endocannabinoid action and metabolism.
Alexander SP; Kendall DA
Br J Pharmacol; 2007 Nov; 152(5):602-23. PubMed ID: 17876303
[TBL] [Abstract][Full Text] [Related]
40. An endocannabinoid hypothesis of drug reward and drug addiction.
Onaivi ES
Ann N Y Acad Sci; 2008 Oct; 1139():412-21. PubMed ID: 18991888
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
